D
Diva R. Salomao
Researcher at Mayo Clinic
Publications - 142
Citations - 9040
Diva R. Salomao is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Biopsy & Fine-needle aspiration. The author has an hindex of 35, co-authored 133 publications receiving 8131 citations. Previous affiliations of Diva R. Salomao include Memorial Sloan Kettering Cancer Center.
Papers
More filters
Journal Article
Infiltrative T regulatory cells in enucleated uveal melanomas.
Evan Lagouros,Diva R. Salomao,Erik C. Thorland,David O. Hodge,Richard G. Vile,Jose S. Pulido +5 more
TL;DR: Though T lymphocyte infiltration is a bad prognostic indicator, Treg cells are rarely seen in enucleated choroidal melanoma, so their local effect may be limited in contradistinction to other cancers.
Journal ArticleDOI
Ocular manifestations of molluscum contagiosum.
TL;DR: Two cases of molluscum contagiosum (MC) are presented to illustrate the range of potential anterior segment complications of this condition.
Journal ArticleDOI
Chordoma. Cytomorphologic findings in 14 cases diagnosed by fine needle aspiration.
TL;DR: Because various cytologic presentations and overlapping cytologic features occur between chordoma, chondrosarcoma and metastatic clear cell carcinoma, it is important to recognize the various appearances of chordoma in FNAB.
Journal ArticleDOI
Rare presentations of primary melanoma and special populations: a systematic review.
Lisa A. Kottschade,Travis E. Grotz,Roxana S. Dronca,Diva R. Salomao,Jose S. Pulido,Nabil Wasif,James W. Jakub,Sanjay P. Bagaria,Riten Kumar,Judith S. Kaur,Shane Y. Morita,Steven L. Moran,Jesse T. Nguyen,Emily C. Nguyen,Jennifer L. Hand,Lori A. Erickson,Jerry D. Brewer,Christian L. Baum,Robert C. Miller,David L. Swanson,Val J. Lowe,Svetomir N. Markovic +21 more
TL;DR: A subset of patients with melanoma present in rare and unique clinical circumstances requiring specific considerations with respect to diagnostic and therapeutic interventions, as well as a discussion of familial melanoma.
Journal Article
Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models
Scott E. Strome,Koji Kawakami,Danielle Alejandro,Stephen G. Voss,Jan L. Kasperbauer,Diva R. Salomao,Lieping Chen,Richard A. Maki,Raj K. Puri +8 more
TL;DR: It is demonstrated that IL-4 (38-37)-PE38KDEL is effective in mediating significant antitumor effects in SCCHN and may represent an attractive therapeutic option for patients with advanced cancers of the upper aerodigestive tract.